Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders
|ClinicalTrials.gov Identifier: NCT00537745|
Recruitment Status : Completed
First Posted : October 1, 2007
Results First Posted : August 27, 2012
Last Update Posted : August 27, 2012
|Condition or disease||Intervention/treatment||Phase|
|Alcohol Consumption||Drug: Vivitrol (Medication Therapy) Other: Medication Management Therapy||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||14 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders-a Pilot Study|
|Study Start Date :||April 2007|
|Primary Completion Date :||May 2009|
|Study Completion Date :||May 2009|
Vivitrol 380 mg/monthly, plus individual compliance enhancement therapy (Medication Management Therapy).
Drug: Vivitrol (Medication Therapy)
Vivitrol 380 mg/monthlyOther: Medication Management Therapy
Medication Management Therapy once a month.
- Evidence of Attempts to Drive After Drinking [ Time Frame: 6 months ]This was measured as Percent of days with an Interlock report of "Failure to Start" due to alcohol pre/on medication and 6 months post medication.
- % Days w/1+Interlock Test Failures [ Time Frame: One month post treatment ]This describes the percent of days in past month where the subject at least 1 interlock test failure.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00537745
|United States, New Mexico|
|Behavioral Health Research Center of the Southwest|
|Albuquerque, New Mexico, United States, 87102|
|Principal Investigator:||Sandra Lapham, MD, MPH||Pacific Institute for Research and Evaluation|